Results 151 to 160 of about 22,551 (179)

Epidermolysis bullosa acquisita (EBA), eine Fallbeschreibung

1994
Die Epidermolysis bullosa acquisita (EBA) gehort zu den chronischen, blasenbildenden Dermatosen. Nach heutigen Erkenntnissen ist die EBA zu den Autoimmunerkrankungen zu zahlen.
M. Bloching, S. Jovanovic, M. Hess, M. Owsianowski   +3 more
openaire   +1 more source

[Manifestation of epidermolysis bullosa acquisita (EBA) in the ENT area].

HNO, 1999
Epidermolysis bullosa acquisita (EBA) is a rare, chronic, acquired bullous autoimmune dermatosis. It is characterized by the formation of IgG autoantibodies against type VII procollagen of anchoring fibrils with subepidermal formation of bullous lesions and consequent scarring.
M, Bloching, E, Dippel, S, Jovanovic, M, Hess, C C, Zouboulis   +4 more
openaire   +1 more source

Epidermolysis bullosa acquisita (EBA) and esophageal webs: a new association.

The American journal of gastroenterology, 1991
Epidermolysis bullosa acquisita (EBA) is a well-defined, blistering disorder of the skin associated with autoantibodies to type VII collagen. Although esophageal pathology is common in children with hereditary dystrophic forms of epidermolysis bullosa, esophageal problems have not been reported previously in patients with bona fide EBA. In this report,
D, Weinman, M I, Stewart, D T, Woodley, G, Garcia   +3 more
openaire   +1 more source

[Epidermolysis bullosa acquisita (EBA). Morphological, immunocytochemical, optical and ultrastructural study about one case (author's transl)].

Annales de pathologie, 1982
Epidermolysis bullosa acquisita (EBA) is a rare non hereditary bullous disease. One case is described with a morphological, and immunocytochemical ultrastructural study. The plain ultrastructural morphology showed a dense amorphous deposit in the superficial dermis, under the basal lamina. Immunofluorescence showed IgG and C3 deposits.
J, Wechsler, V, Tricottet, F, Capron, M, Galtier, Y, de Prost, M, Reynes   +5 more
openaire   +1 more source

Drug repurposing as a successful principle to identify drugs that alleviate experimental epidermolysis bullosa acquisita (EBA)

2018
Epidermolysis bullosa acquisita (EBA) is a prototypic immunobullous disorder caused by autoantibodies directed against type VII collagen (COL7), which is the major component of the anchoring fibrils at the dermal epidermal junction. Treatment of EBA is difficult and more specifically relies on general immunosuppression.
Ghorbanalipoor, S., Veldkamp, W., Matsumoto, K., Bieber, K., Vidarsson, G., Gupta, Y., Kuenzel, S., Schwaninger, M., Kalies, K., Ludwig, R.   +9 more
openaire   +1 more source

Therapeutische Kinasehemmung in einem neuartigen humanisierten Mausmodell der Epidermolysis bullosa acquisita (EBA)

Epidermolysis bullosa acquisita (EBA) ist eine seltene, chronische Autoimmunerkrankung der Haut aus der Gruppe der pemphigoiden Dermatosen. Pathogenetisch richten sich Autoantikörper gegen Kollagen VII (COL7c), ein Schlüsselprotein der Hemidesmosomen in der Basalmembranzone (BMZ) bzw. dermal-epidermalen Junktionszone (DEJ).
openaire   +1 more source

Pediatric Epidermolysis Bullosa Acquisita: A Review

Pediatric Dermatology, 2021
Naveed Sami
exaly  

Susceptibility to experimental epidermolysis bullosa acquisita (EBA) is correlated with expression of TH1 cytokines

Journal of the American Academy of Dermatology, 2010
openaire   +1 more source

An Atypical Case of Pediatric Epidermolysis Bullosa Acquisita: Review of Diagnosis and Pitfalls

JAAD Case Reports, 2021
Leah Lalor, Karolyn A Wanat
exaly